Invention Grant
- Patent Title: Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer's and vascular dementia
-
Application No.: US14749408Application Date: 2015-06-24
-
Publication No.: US09708372B2Publication Date: 2017-07-18
- Inventor: Marion Bimmler , Peter Karczewski , Petra Hempel
- Applicant: E.R.D.E.-AAK-DIAGNOSTIK GMBH , MAX-DEL-BRUCK-CENTRUM FÜR MOLEKULARE MEDIZIN
- Applicant Address: DE Berlin DE Berlin
- Assignee: E.R.D.E.-AAK-DIAGNOSTIK GMBH,MAX-DEL-BRUCK-CENTRUM FÜR MOLEKULARE MEDIZIN
- Current Assignee: E.R.D.E.-AAK-DIAGNOSTIK GMBH,MAX-DEL-BRUCK-CENTRUM FÜR MOLEKULARE MEDIZIN
- Current Assignee Address: DE Berlin DE Berlin
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: EP11177414 20110812
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K16/18 ; G01N33/566 ; C07K14/705 ; A61M1/36 ; G01N33/564
Abstract:
The invention relates to means for detecting, binding, removing and/or neutralizing agonistic antibodies associated with dementia, preferably Alzheimer's disease or vascular dementia.
Public/Granted literature
Information query
